Abstract

A better understanding of the mechanisms involved in megakaryocyte maturation will facilitate the generation of platelets in vitro and their clinical applications. A microRNA, miR-125b, has been suggested to have important roles in the self-renewal of megakaryocyte-erythroid progenitors and in platelet generation. However, miR-125b is also critical for hematopoietic stem cell self-renewal. Thus, the function of miR-125b and the complex signaling pathways regulating megakaryopoiesis remain to be elucidated. In this study, an attentive examination of the endogenous expression of miR-125b during megakaryocyte differentiation was performed. Accordingly, the differentiation of hematopoietic stem cells requires the downregulation of miR-125b, whereas megakaryocyte determination and maturation synchronize with miR-125b accumulation. The overexpression of miR-125b improves megakaryocytic differentiation of K562 and UT-7 cells. Furthermore, stage-specific overexpression of miR-125b in primary cells demonstrates that miR-125b mediates an enhancement of megakaryocytic differentiation after megakaryocyte determination, the stage at which megakaryocytes are negative for the expression of the hematopoietic progenitor marker CD34. The identification of miR-125b targets during megakaryopoiesis was focused on negative regulators of cell cycle because the transition of the G1/S phase has been associated with megakaryocyte polyploidization. Real-time PCR, western blot and luciferase reporter assay reveal that p19INK4D is a direct target of miR-125b. P19INK4D knockdown using small interfering RNA (siRNA) in megakaryocyte-induced K562 cells, UT-7 cells and CD61+ promegakaryocytes results in S-phase progression and increased polyploidy, as well as improved megakaryocyte differentiation, similarly to the effects of miR-125b overexpression. P19INK4D overexpression reverses these effects, as indicated by reduced expression of megakaryocyte markers, G1-phase arrest and polyploidy decrease. P19INK4D knockdown in miR-125b downregulated cells or p19INK4D overexpression in miR-125b upregulated cells rescued the effect of miR-125b. Taken together, these findings suggest that miR-125b expression positively regulates megakaryocyte development since the initial phases of megakaryocyte determination, and p19INK4D is one of the key mediators of miR-125b activity during the onset of megakaryocyte polyploidization.

Highlights

  • Thrombocytopenia, the deficiency of platelets (PLTs) in the blood, threatens millions of people, including patients undergoing high-dose chemotherapy, and subjects affected by aplastic anemia or hepatitis virus-related cirrhosis

  • To gain insight into the role of miR-125b in MK differentiation, we investigated the endogenous expression of miR-125b in hematopoietic stem cells (HSCs)-MK differentiation

  • The expression of miR-125b was markedly elevated in PLTs isolated from cord blood (CB) (Figure 1b) (4200-fold) compared with undifferentiated CD34+ hematopoietic cells (Figure 1d, left panel)

Read more

Summary

Introduction

Thrombocytopenia, the deficiency of platelets (PLTs) in the blood, threatens millions of people, including patients undergoing high-dose chemotherapy, and subjects affected by aplastic anemia or hepatitis virus-related cirrhosis. The study by Klusmann et al.[4] suggests that Dicer and ST18 were direct targets of miR-125b in megakaryocytopoiesis, both of these factors are common to several cellular processes.[6] Considering the significant effect of miR-125b on cell proliferation and endomitosis of MK progenitors and MKs, it is reasonable to speculate that miR-125b may regulate the expression of cellcycle inhibitors. We systematically identified the role of miR-125b in the differentiation of MKs and one of the target genes that mediate its function, the cell-cycle inhibitor p19INK4D

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call